Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2006; 12(40): 6522-6526
Published online Oct 28, 2006. doi: 10.3748/wjg.v12.i40.6522
Published online Oct 28, 2006. doi: 10.3748/wjg.v12.i40.6522
Table 1 Patient profile
| n | Site of metastases | ||
| Sex | |||
| Female | 20 | Lymph nodes | 26 |
| Male | 11 | Perigastric | 6 |
| PS | Para-aortic | 6 | |
| 0 | 21 | Virchow’s | 3 |
| 1 | 9 | Neck | 2 |
| 2 | 1 | Mediastinum | 1 |
| Histology | Others | 8 | |
| Intestinal | 16 | Liver | 13 |
| Diffuse | 14 | Peritoneal | 3 |
| Others | 1 | Skin | 1 |
| Prior chemotherapy | Lung | 1 | |
| No | 20 | Ovary | 2 |
| Yes | 11 | Rectum | 1 |
- Citation: Imamura H, Ikeda M, Furukawa H, Tsujinaka T, Fujitani K, Kobayashi K, Narahara H, Kato M, Imamoto H, Takabayashi A, Tsukuma H. Phase II study of protracted irinotecan infusion and a low-dose cisplatin for metastatic gastric cancer. World J Gastroenterol 2006; 12(40): 6522-6526
- URL: https://www.wjgnet.com/1007-9327/full/v12/i40/6522.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i40.6522